Helen E. Kent
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 10%
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 4
-
- Cytomegalovirus and herpesvirus research 1
- Co-authors
- Stephen J. Kent (9 shared papers)Arnold Reynaldi (6 shared papers)Jennifer A. Juno (8 shared papers)Wen Shi Lee (6 shared papers)Miles P. Davenport (7 shared papers)Adam K. Wheatley (6 shared papers)Hyon‐Xhi Tan (3 shared papers)Kathleen M. Wragg (3 shared papers)
In The Last Decade
Helen E. Kent
12 papers receiving 379 citations
Peers
Comparison fields: 5 of 58
- Infectious Diseases 291
- Modeling and Simulation 28
- Immunology 104
- Neurology 70
- Health 27
Countries citing papers authored by Helen E. Kent
This map shows the geographic impact of Helen E. Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Kent more than expected).
Fields of papers citing papers by Helen E. Kent
This network shows the impact of papers produced by Helen E. Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Kent. The network helps show where Helen E. Kent may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen E. Kent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 260 | |
| 2 | 2024 | 28 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 23 | |
| 5 | 2021 | 11 | |
| 6 | 2023 | 10 | |
| 7 | 2020 | 9 | |
| 8 | 2008 | 8 | |
| 9 | 2022 | 4 | |
| 10 | 1998 | 3 | |
| 11 | 2021 | 1 | |
| 12 | 2023 | 1 |
About Helen E. Kent
Helen E. Kent is a scholar working on Infectious Diseases, Epidemiology, Immunology, Molecular Biology and Virology, having authored 12 papers that have together received 386 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers), HIV Research and Treatment (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Ocular Surface and Contact Lens (1 paper), Poxvirus research and outbreaks (1 paper), Viral-associated cancers and disorders (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Infectious Diseases (291 citations), Modeling and Simulation (28 citations), Immunology (104 citations), Neurology (70 citations) and Health (27 citations). Helen E. Kent has collaborated with scholars based in Australia, Singapore and Canada. Frequent co-authors include Stephen J. Kent, Arnold Reynaldi, Jennifer A. Juno, Wen Shi Lee, Miles P. Davenport, Adam K. Wheatley, Hyon‐Xhi Tan, Kathleen M. Wragg, Robyn Esterbauer and Melanie H. Dietrich. Their work appears in journals such as Immunology and Cell Biology, Nature Medicine, Journal of Clinical Medicine, The Ocular Surface and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.